 Process GO Term   physiological processes    And related genes <body> Process GO Term physiological processes  and related genes   Total 3930 
Page number 45 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81   |   82   |   83   |   84   |   85   |   86   |   87   |   88   |   89   |   90   |   91   |   92   |   93   |   94   |   95   |   96   |   97   |   98   |   99   |   100   |   101   |   102   |   103   |   104   |   105   |   106   |   107   |   108   |   109   |   110   |   111   |   112   |   113   |   114   |   115   |   116   |   117   |   118   |   119   |   120   |   121   |   122   |   123   |   124   |   125   |   126   |   127   |   128   |   129   |   130   |   132  
    Gene Name  ORF Name  Function GO Term   Process GO Term   Component GO Term  Interacting Genes  Description  Gene Product  Phenotype     HXT5   YHR096C  glucose transporter activity*   hexose transport   plasma membrane  YLL020C	YDL047W	  Member of superfamily of monosaccharide transporters  hexose transporter  Null mutant is viable     HXT6   YDR343C  glucose transporter activity*   hexose transport   plasma membrane  YER081W	YKL193C	YOL100W	YBL036C	YER125W	YNL032W	YER171W	YLR019W	YGR040W	YOR181W	YJR017C	  Repression of HXT6 expression by glucose requires SNF3  hexose transporter  Null mutant is viable; snf3 hxt1 hxt2 hxt3 hxt4 hxt6 hxt7 mutant cannot grow on media containing glu     HXT7   YDR342C  glucose transporter activity*   hexose transport   plasma membrane  YDR034C	YER048C	YPL204W	YCL039W	YOL100W	YBL036C	YCR088W	YJL173C	YLR019W	YLR340W	YNL323W	YOR181W	YKR026C	YMR049C	  Hexose transporter  hexose transporter  Null mutant is viable; snf3 hxt1 hxt2 hxt3 hxt4 HXT7 hxt7 mutant cannot grow on media containing glu     HXT8   YJL214W  glucose transporter activity*   hexose transport   plasma membrane  YNL192W	  High-affinity hexose transporter  hexose permease       HXT9   YJL219W  glucose transporter activity*   hexose transport   plasma membrane  YLR447C	  High-affinity hexose transporter  hexose permease  Null mutant is viable, cycloheximide, sulfomethuron methyl, and 4-NQO (4-nitroquinoline-N-oxide) res     HYM1   YKL189W  transcriptional repressor activity   cytokinesis, completion of separation*   intracellular  YMR303C	YKL010C	YMR058W	YDL065C	YHR102W	YFL016C	  Cbk1p and Hym1p regulate two distinct cell morphogenesis pathways: an ACE2-indep. pathway req'd for    Null mutant is inviable     HYP2   YEL034W  translation initiation factor activity   translational initiation   cytoplasm*  YBR272C	YOL069W	YPL204W	YOR043W	YHR135C	YDR394W	YPL111W	YMR284W	YLR340W	YOL133W	YHR166C	YBR055C	YLR074C	YBR109C	YBR135W	  Translation initiation factor eIF-5A  translation initiation factor eIF-5A  Null mutant is viable; a double mutant containing disruptions of both HYP2 and and the highly homolo     HYR1   YIR037W  thiol peroxidase activity*   response to oxidative stress   intracellular  YMR047C	YLR216C	  Hydroperoxide resistance conferring gene. Sensor and transducer of the hydroperoxide signal to Yap1.  glutathione-peroxidase (putative)  Null mutant is hypersensitive to oxidative stress     HYS2   YJR006W  delta DNA polymerase activity   lagging strand elongation*   delta DNA polymerase complex  YJR043C	YDL102W	YLR447C	  Putative role in DNA replication  DNA polymerase delta 55 kDa subunit  Null mutant is inviable     IAH1   YOR126C  hydrolase activity, acting on ester bonds   acetate metabolism   cellular_component unknown    isoamyl acetate-hydrolyzing esterase  isoamyl acetate-hydrolyzing esterase  The null mutant is viable but cannot hydrolyze isoamyl acetate.     IBD2   YNL164C  molecular_function unknown   mitotic spindle checkpoint   nucleus  YGR218W	YNL091W	   I nhibition of  B ud  D ivision    Null: viable, sensitive to benomyl     ICL1   YER065C  isocitrate lyase activity   glyoxylate cycle   cellular_component unknown  YNL189W	YGL062W	YBR009C	YBR218C	  component of glyoxylate cycle  isocitrate lyase  Null mutant is viable, fails to grow on ethanol as a carbon source     ICL2   YPR006C  methylisocitrate lyase activity   propionate metabolism*   mitochondrial matrix  YLR447C	  2-methylisocitrate lyase  2-methylisocitrate lyase  Null mutant is viable     IDH1   YNL037C  isocitrate dehydrogenase (NAD) activity   tricarboxylic acid cycle*   mitochondrial matrix  YOL082W	YOR136W	YDR523C	YLR097C	YER020W	YML057W	YDR388W	YHR030C	YPL140C	YGL137W	YOL133W	YMR106C	YAL015C	  alpha-4-beta-4 subunit of mitochondrial isocitrate dehydrogenase 1  isocitrate dehydrogenase 1 alpha-4-beta-4 subunit  Null mutant is viable, grows at a reduced rate on glycerol, lactate, and acetate     IDH2   YOR136W  isocitrate dehydrogenase (NAD) activity   tricarboxylic acid cycle*   mitochondrion*  YDR127W	YBL022C	YDR170C	YDR373W	YER022W	YJL015C	YNL037C	YNL189W	YPR110C	YPR111W	YGL208W	YER171W	YHR014W	YGL158W	YDR394W	  NAD+-dependent isocitrate dehydrogenase  NAD-dependent isocitrate dehydrogenase  Null mutant is viable     IDI1   YPL117C  isopentenyl-diphosphate delta-isomerase activity   ergosterol biosynthesis   cytosol    catalyzes activation step in isoprenoid biosynthetic pathway  isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IPP isomerase)  Null mutant is inviable     IDP1   YDL066W  isocitrate dehydrogenase (NADP) activity   glutamate biosynthesis*   mitochondrion  YMR047C	  Mitochondrial form of NADP-specific isocitrate dehydrogenase  NADP-dependent isocitrate dehydrogenase  Null mutant is viable     IDP2   YLR174W  isocitrate dehydrogenase (NADP) activity   glutamate biosynthesis*   cytosol  YNR065C	YGR262C	  concerts isocitrate and NADP+ to 2-oxoglutarate, CO2, and NADPH  NADP-dependent isocitrate dehydrogenase  Null mutant is viable     IDP3   YNL009W  isocitrate dehydrogenase (NADP) activity   fatty acid beta-oxidation*   cytoplasm*  YLR295C	  peroxisomal NADP-dependent isocitrate dehydrogenase  NADP-dependent isocitrate dehydrogenase  Null mutant is viable but is unable to grow on polyunsaturated fatty acids as sole carbon source     IDS2   YJL146W  molecular_function unknown   meiosis   cellular_component unknown  YDL043C	  IME2-Dependent Signalling    Null mutations reduce or abolish the ability of IME2p to activate expression of early, middle, and l     IFH1   YLR223C  molecular_function unknown   rRNA processing*   cellular_component unknown  YBR119W	YOR247W	YCL032W	  Interacts with fork head protein. Protein controlling pre-rRNA processing machinery in conjunction w  weak RNA-dependent ATPase activity which is not specific for rRNA  Null mutant is inviable, ifh1 fhl1 double deletion mutant is viable     IFM1   YOL023W  RNA binding*   translational initiation   mitochondrion  YDR420W	YGR143W	  mitochondrial initiation factor 2  mitochondrial initiation factor 2  Null mutant is viable but is respiratory-deficient and has defects in mitochondrial protein synthesi     IKI1   YHR187W  Pol II transcription elongation factor activity   regulation of transcription from Pol II promoter   transcription elongation factor complex*  YGR200C	YMR047C	YMR312W	  RNA polymerase II Elongator associated protein    Null mutant is viable but is insensitive to pGLK killer toxin; zymotoxin resistant; slow growth; the     IKI3   YLR384C  Pol II transcription elongation factor activity*   regulation of transcription from Pol II promoter   transcription elongation factor complex*  YDR461W	YGR200C	YER016W	YLR418C	YGR229C	YAL013W	YDR126W	  RNA polymerase II Elongator subunit    Null mutant is viable; insensitive to pGKL killer toxin; zymotoxin resistant; slow growth; thermo-se     ILS1   YBL076C  isoleucine-tRNA ligase activity   protein biosynthesis   cytosol  YBR058C	YDL100C	YNL244C	YPR110C	YOR080W	YBR055C	YBR109C	YLR016C	  cytoplasmic isoleucyl-tRNA synthetase  isoleucine-tRNA synthetase  Arrests in early G1 at nonpermissive temperature of 36 degrees C     ILV1   YER086W  threonine ammonia-lyase activity   branched chain family amino acid biosynthesis   cellular_component unknown  YER086W	YER095W	YKL081W	YBR162C	YDL044C	YDL239C	YDR311W	YHL004W	YKL057C	YOR383C	YPL070W	  threonine deaminase  threonine deaminase  Isoleucine-plus-valine requiring     ILV2   YMR108W  acetolactate synthase activity   branched chain family amino acid biosynthesis   mitochondrion  YDL059C	YMR106C	YNL128W	  acetolactate synthase  acetolactate synthase  Isoleucine-plus-valine requiring; Sulfometuron methyl resistance     ILV3   YJR016C  dihydroxy-acid dehydratase activity   branched chain family amino acid biosynthesis   mitochondrion  YPR165W	  catalyzes third step in common pathway leading to biosynthesis of branched-chain amino acids  dihydroxyacid dehydratase  Null mutant is viable and requires isoleucine and valine     ILV5   YLR355C  ketol-acid reductoisomerase activity   mitochondrial genome maintenance*   mitochondrion  YHR135C	YBR155W	YDR388W	YHR030C	YLR442C	YDR499W	  branched-chain amino acid biosynthesis  acetohydroxyacid reductoisomerase  Isoleucine-plus-valine requiring     ILV6   YCL009C  enzyme regulator activity*   branched chain family amino acid biosynthesis   mitochondrion  YER094C	YIL034C	YLR288C	  acetolactate synthase regulatory subunit       </body> 